Skip to content

Screening of new markers of gut microbiota in stroke and depression: a cross-sectional study

Screening of new markers of gut microbiota in stroke and depression: a cross-sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075368
Enrollment
Unknown
Registered
2023-09-02
Start date
2023-09-02
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, depression

Interventions

Stroke group:None
Depression group:None
Healthy controls:None

Sponsors

Zhujiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for stroke patients: (1) Ages ranged from 18-75 years; (2) Patients who met the diagnostic criteria of the 2018 Chinese guidelines for the diagnosis and treatment of acute ischemic stroke; (3) Sign the informed consent form, provide relevant medical history information and provide blood, urine and stool samples. 2. inclusion criteria for depressed patients: (1) Age ranged from 18-75 years; (2) Patients who met the depression related criteria in the Chinese classification and diagnostic criteria for mental disorders; (3) Sign the informed consent form, provide relevant medical history information and provide oral swabs, blood, urine and stool samples. 3. inclusion criteria for healthy control: (1) Non-diseased people from the general community living in the city of their location for the last three years; (2) Sex and age matched with stroke and depression patients, respectively; (3) Signed informed consent, provided relevant medical history information and provided biospecimens.

Exclusion criteria

Exclusion criteria: 1. Exclusion criteria for stroke and depression patients: (1) Serious systemic diseases including malignancies; (2) Alanine aminotransferase or aspartate aminotransferase >2 times the upper limit of normal value or severe liver disease; (3) Creatinine >1.5 times the upper limit of normal or severe nephropathy; (4) A long-term history of drinking, drug taking and chemical poisoning. A long-term history of drinking refers to a history of more than 5 years, equivalent to alcohol >40g/d for men and 20g/d for women, or a history of heavy drinking within 2 weeks, equivalent to alcohol >80g/d; (5) Those with previous history of intestinal tumor, irritable bowel syndrome or inflammatory bowel disease or diagnosed in Hospital; (6) Unable to retain the required samples. 2.Exclusion criteria for healthy control: (1) History of inflammatory bowel disease, prolonged diarrhea or constipation, malignancy, history of cardiac infarction or any stroke, and history of other major diseases; (2) Use of antibiotics within the last three months; (3) Use of metformin, statins, probiotics/probiotics in the last three months; (4) Recent heavy alcohol consumption or a history of chronic alcohol consumption; (5) History of drug use and chemical poisoning (such as pesticide poisoning).

Design outcomes

Primary

MeasureTime frame
Microbiome;metabolome;

Secondary

MeasureTime frame
National Institutes of Health Stroke Scale;Modified Rankin Scale;Hamilton Depression Scale;Montgomery-Asberg Depression Rating Scale;

Countries

China

Contacts

Public ContactHongwei Zhou

Zhujiang Hospital of Southern Medical University

hzhou@smu.edu.cn+86 186 8848 9622

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026